Central Nervous System (CNS) Stimulant Drugs Market, Global Outlook and Forecast 2022-2028
Central Nervous System (CNS) Stimulant Drug has its own characteristic mechanism of action on CNS neurones and their associated receptors and nerve terminals.
This report contains market size and forecasts of Central Nervous System (CNS) Stimulant Drugs in global, including the following market information:
Global Central Nervous System (CNS) Stimulant Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Central Nervous System (CNS) Stimulant Drugs Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Central Nervous System (CNS) Stimulant Drugs companies in 2021 (%)
The global Central Nervous System (CNS) Stimulant Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Amphetamine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Central Nervous System (CNS) Stimulant Drugs include Astellas Pharma, Biogen, Celltech, Eli Lilly and Company, GlaxoSmithKline, Johnson and Johnson, Merck, Novartis and Perdue Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Central Nervous System (CNS) Stimulant Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Central Nervous System (CNS) Stimulant Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Central Nervous System (CNS) Stimulant Drugs Market Segment Percentages, by Type, 2021 (%)
Global Central Nervous System (CNS) Stimulant Drugs Market Segment Percentages, by Application, 2021 (%)
Global Central Nervous System (CNS) Stimulant Drugs Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Central Nervous System (CNS) Stimulant Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Central Nervous System (CNS) Stimulant Drugs revenues share in global market, 2021 (%)
Key companies Central Nervous System (CNS) Stimulant Drugs sales in global market, 2017-2022 (Estimated), (MT)
Key companies Central Nervous System (CNS) Stimulant Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Central Nervous System (CNS) Stimulant Drugs in global, including the following market information:
Global Central Nervous System (CNS) Stimulant Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Central Nervous System (CNS) Stimulant Drugs Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Central Nervous System (CNS) Stimulant Drugs companies in 2021 (%)
The global Central Nervous System (CNS) Stimulant Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Amphetamine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Central Nervous System (CNS) Stimulant Drugs include Astellas Pharma, Biogen, Celltech, Eli Lilly and Company, GlaxoSmithKline, Johnson and Johnson, Merck, Novartis and Perdue Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Central Nervous System (CNS) Stimulant Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Central Nervous System (CNS) Stimulant Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Central Nervous System (CNS) Stimulant Drugs Market Segment Percentages, by Type, 2021 (%)
- Amphetamine
- Cocaine
- Caffeine
- Others
Global Central Nervous System (CNS) Stimulant Drugs Market Segment Percentages, by Application, 2021 (%)
- Attention Deficit Hyperactivity Disorder (ADHD)
- Narcolepsy
- Others
Global Central Nervous System (CNS) Stimulant Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Central Nervous System (CNS) Stimulant Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Central Nervous System (CNS) Stimulant Drugs revenues share in global market, 2021 (%)
Key companies Central Nervous System (CNS) Stimulant Drugs sales in global market, 2017-2022 (Estimated), (MT)
Key companies Central Nervous System (CNS) Stimulant Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Astellas Pharma
- Biogen
- Celltech
- Eli Lilly and Company
- GlaxoSmithKline
- Johnson and Johnson
- Merck
- Novartis
- Perdue Pharma
- Pfizer
- Roche
- Sanofi
- Shire
- Takeda Pharmaceuticals
- Thermo Fisher Scientific
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Central Nervous System (CNS) Stimulant Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Central Nervous System (CNS) Stimulant Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL CENTRAL NERVOUS SYSTEM (CNS) STIMULANT DRUGS OVERALL MARKET SIZE
2.1 Global Central Nervous System (CNS) Stimulant Drugs Market Size: 2021 VS 2028
2.2 Global Central Nervous System (CNS) Stimulant Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Central Nervous System (CNS) Stimulant Drugs Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Central Nervous System (CNS) Stimulant Drugs Players in Global Market
3.2 Top Global Central Nervous System (CNS) Stimulant Drugs Companies Ranked by Revenue
3.3 Global Central Nervous System (CNS) Stimulant Drugs Revenue by Companies
3.4 Global Central Nervous System (CNS) Stimulant Drugs Sales by Companies
3.5 Global Central Nervous System (CNS) Stimulant Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Central Nervous System (CNS) Stimulant Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Central Nervous System (CNS) Stimulant Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Central Nervous System (CNS) Stimulant Drugs Players in Global Market
3.8.1 List of Global Tier 1 Central Nervous System (CNS) Stimulant Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Central Nervous System (CNS) Stimulant Drugs Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Central Nervous System (CNS) Stimulant Drugs Market Size Markets, 2021 & 2028
4.1.2 Amphetamine
4.1.3 Cocaine
4.1.4 Caffeine
4.1.5 Others
4.2 By Type - Global Central Nervous System (CNS) Stimulant Drugs Revenue & Forecasts
4.2.1 By Type - Global Central Nervous System (CNS) Stimulant Drugs Revenue, 2017-2022
4.2.2 By Type - Global Central Nervous System (CNS) Stimulant Drugs Revenue, 2023-2028
4.2.3 By Type - Global Central Nervous System (CNS) Stimulant Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Central Nervous System (CNS) Stimulant Drugs Sales & Forecasts
4.3.1 By Type - Global Central Nervous System (CNS) Stimulant Drugs Sales, 2017-2022
4.3.2 By Type - Global Central Nervous System (CNS) Stimulant Drugs Sales, 2023-2028
4.3.3 By Type - Global Central Nervous System (CNS) Stimulant Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Central Nervous System (CNS) Stimulant Drugs Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Central Nervous System (CNS) Stimulant Drugs Market Size, 2021 & 2028
5.1.2 Attention Deficit Hyperactivity Disorder (ADHD)
5.1.3 Narcolepsy
5.1.4 Others
5.2 By Application - Global Central Nervous System (CNS) Stimulant Drugs Revenue & Forecasts
5.2.1 By Application - Global Central Nervous System (CNS) Stimulant Drugs Revenue, 2017-2022
5.2.2 By Application - Global Central Nervous System (CNS) Stimulant Drugs Revenue, 2023-2028
5.2.3 By Application - Global Central Nervous System (CNS) Stimulant Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Central Nervous System (CNS) Stimulant Drugs Sales & Forecasts
5.3.1 By Application - Global Central Nervous System (CNS) Stimulant Drugs Sales, 2017-2022
5.3.2 By Application - Global Central Nervous System (CNS) Stimulant Drugs Sales, 2023-2028
5.3.3 By Application - Global Central Nervous System (CNS) Stimulant Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Central Nervous System (CNS) Stimulant Drugs Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Central Nervous System (CNS) Stimulant Drugs Market Size, 2021 & 2028
6.2 By Region - Global Central Nervous System (CNS) Stimulant Drugs Revenue & Forecasts
6.2.1 By Region - Global Central Nervous System (CNS) Stimulant Drugs Revenue, 2017-2022
6.2.2 By Region - Global Central Nervous System (CNS) Stimulant Drugs Revenue, 2023-2028
6.2.3 By Region - Global Central Nervous System (CNS) Stimulant Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Central Nervous System (CNS) Stimulant Drugs Sales & Forecasts
6.3.1 By Region - Global Central Nervous System (CNS) Stimulant Drugs Sales, 2017-2022
6.3.2 By Region - Global Central Nervous System (CNS) Stimulant Drugs Sales, 2023-2028
6.3.3 By Region - Global Central Nervous System (CNS) Stimulant Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Central Nervous System (CNS) Stimulant Drugs Revenue, 2017-2028
6.4.2 By Country - North America Central Nervous System (CNS) Stimulant Drugs Sales, 2017-2028
6.4.3 US Central Nervous System (CNS) Stimulant Drugs Market Size, 2017-2028
6.4.4 Canada Central Nervous System (CNS) Stimulant Drugs Market Size, 2017-2028
6.4.5 Mexico Central Nervous System (CNS) Stimulant Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Central Nervous System (CNS) Stimulant Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Central Nervous System (CNS) Stimulant Drugs Sales, 2017-2028
6.5.3 Germany Central Nervous System (CNS) Stimulant Drugs Market Size, 2017-2028
6.5.4 France Central Nervous System (CNS) Stimulant Drugs Market Size, 2017-2028
6.5.5 U.K. Central Nervous System (CNS) Stimulant Drugs Market Size, 2017-2028
6.5.6 Italy Central Nervous System (CNS) Stimulant Drugs Market Size, 2017-2028
6.5.7 Russia Central Nervous System (CNS) Stimulant Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Central Nervous System (CNS) Stimulant Drugs Market Size, 2017-2028
6.5.9 Benelux Central Nervous System (CNS) Stimulant Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Central Nervous System (CNS) Stimulant Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Central Nervous System (CNS) Stimulant Drugs Sales, 2017-2028
6.6.3 China Central Nervous System (CNS) Stimulant Drugs Market Size, 2017-2028
6.6.4 Japan Central Nervous System (CNS) Stimulant Drugs Market Size, 2017-2028
6.6.5 South Korea Central Nervous System (CNS) Stimulant Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Central Nervous System (CNS) Stimulant Drugs Market Size, 2017-2028
6.6.7 India Central Nervous System (CNS) Stimulant Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Central Nervous System (CNS) Stimulant Drugs Revenue, 2017-2028
6.7.2 By Country - South America Central Nervous System (CNS) Stimulant Drugs Sales, 2017-2028
6.7.3 Brazil Central Nervous System (CNS) Stimulant Drugs Market Size, 2017-2028
6.7.4 Argentina Central Nervous System (CNS) Stimulant Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Sales, 2017-2028
6.8.3 Turkey Central Nervous System (CNS) Stimulant Drugs Market Size, 2017-2028
6.8.4 Israel Central Nervous System (CNS) Stimulant Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Central Nervous System (CNS) Stimulant Drugs Market Size, 2017-2028
6.8.6 UAE Central Nervous System (CNS) Stimulant Drugs Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Astellas Pharma
7.1.1 Astellas Pharma Corporate Summary
7.1.2 Astellas Pharma Business Overview
7.1.3 Astellas Pharma Central Nervous System (CNS) Stimulant Drugs Major Product Offerings
7.1.4 Astellas Pharma Central Nervous System (CNS) Stimulant Drugs Sales and Revenue in Global (2017-2022)
7.1.5 Astellas Pharma Key News
7.2 Biogen
7.2.1 Biogen Corporate Summary
7.2.2 Biogen Business Overview
7.2.3 Biogen Central Nervous System (CNS) Stimulant Drugs Major Product Offerings
7.2.4 Biogen Central Nervous System (CNS) Stimulant Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Biogen Key News
7.3 Celltech
7.3.1 Celltech Corporate Summary
7.3.2 Celltech Business Overview
7.3.3 Celltech Central Nervous System (CNS) Stimulant Drugs Major Product Offerings
7.3.4 Celltech Central Nervous System (CNS) Stimulant Drugs Sales and Revenue in Global (2017-2022)
7.3.5 Celltech Key News
7.4 Eli Lilly and Company
7.4.1 Eli Lilly and Company Corporate Summary
7.4.2 Eli Lilly and Company Business Overview
7.4.3 Eli Lilly and Company Central Nervous System (CNS) Stimulant Drugs Major Product Offerings
7.4.4 Eli Lilly and Company Central Nervous System (CNS) Stimulant Drugs Sales and Revenue in Global (2017-2022)
7.4.5 Eli Lilly and Company Key News
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Corporate Summary
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Central Nervous System (CNS) Stimulant Drugs Major Product Offerings
7.5.4 GlaxoSmithKline Central Nervous System (CNS) Stimulant Drugs Sales and Revenue in Global (2017-2022)
7.5.5 GlaxoSmithKline Key News
7.6 Johnson and Johnson
7.6.1 Johnson and Johnson Corporate Summary
7.6.2 Johnson and Johnson Business Overview
7.6.3 Johnson and Johnson Central Nervous System (CNS) Stimulant Drugs Major Product Offerings
7.6.4 Johnson and Johnson Central Nervous System (CNS) Stimulant Drugs Sales and Revenue in Global (2017-2022)
7.6.5 Johnson and Johnson Key News
7.7 Merck
7.7.1 Merck Corporate Summary
7.7.2 Merck Business Overview
7.7.3 Merck Central Nervous System (CNS) Stimulant Drugs Major Product Offerings
7.7.4 Merck Central Nervous System (CNS) Stimulant Drugs Sales and Revenue in Global (2017-2022)
7.7.5 Merck Key News
7.8 Novartis
7.8.1 Novartis Corporate Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Central Nervous System (CNS) Stimulant Drugs Major Product Offerings
7.8.4 Novartis Central Nervous System (CNS) Stimulant Drugs Sales and Revenue in Global (2017-2022)
7.8.5 Novartis Key News
7.9 Perdue Pharma
7.9.1 Perdue Pharma Corporate Summary
7.9.2 Perdue Pharma Business Overview
7.9.3 Perdue Pharma Central Nervous System (CNS) Stimulant Drugs Major Product Offerings
7.9.4 Perdue Pharma Central Nervous System (CNS) Stimulant Drugs Sales and Revenue in Global (2017-2022)
7.9.5 Perdue Pharma Key News
7.10 Pfizer
7.10.1 Pfizer Corporate Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Central Nervous System (CNS) Stimulant Drugs Major Product Offerings
7.10.4 Pfizer Central Nervous System (CNS) Stimulant Drugs Sales and Revenue in Global (2017-2022)
7.10.5 Pfizer Key News
7.11 Roche
7.11.1 Roche Corporate Summary
7.11.2 Roche Central Nervous System (CNS) Stimulant Drugs Business Overview
7.11.3 Roche Central Nervous System (CNS) Stimulant Drugs Major Product Offerings
7.11.4 Roche Central Nervous System (CNS) Stimulant Drugs Sales and Revenue in Global (2017-2022)
7.11.5 Roche Key News
7.12 Sanofi
7.12.1 Sanofi Corporate Summary
7.12.2 Sanofi Central Nervous System (CNS) Stimulant Drugs Business Overview
7.12.3 Sanofi Central Nervous System (CNS) Stimulant Drugs Major Product Offerings
7.12.4 Sanofi Central Nervous System (CNS) Stimulant Drugs Sales and Revenue in Global (2017-2022)
7.12.5 Sanofi Key News
7.13 Shire
7.13.1 Shire Corporate Summary
7.13.2 Shire Central Nervous System (CNS) Stimulant Drugs Business Overview
7.13.3 Shire Central Nervous System (CNS) Stimulant Drugs Major Product Offerings
7.13.4 Shire Central Nervous System (CNS) Stimulant Drugs Sales and Revenue in Global (2017-2022)
7.13.5 Shire Key News
7.14 Takeda Pharmaceuticals
7.14.1 Takeda Pharmaceuticals Corporate Summary
7.14.2 Takeda Pharmaceuticals Business Overview
7.14.3 Takeda Pharmaceuticals Central Nervous System (CNS) Stimulant Drugs Major Product Offerings
7.14.4 Takeda Pharmaceuticals Central Nervous System (CNS) Stimulant Drugs Sales and Revenue in Global (2017-2022)
7.14.5 Takeda Pharmaceuticals Key News
7.15 Thermo Fisher Scientific
7.15.1 Thermo Fisher Scientific Corporate Summary
7.15.2 Thermo Fisher Scientific Business Overview
7.15.3 Thermo Fisher Scientific Central Nervous System (CNS) Stimulant Drugs Major Product Offerings
7.15.4 Thermo Fisher Scientific Central Nervous System (CNS) Stimulant Drugs Sales and Revenue in Global (2017-2022)
7.15.5 Thermo Fisher Scientific Key News
8 GLOBAL CENTRAL NERVOUS SYSTEM (CNS) STIMULANT DRUGS PRODUCTION CAPACITY, ANALYSIS
8.1 Global Central Nervous System (CNS) Stimulant Drugs Production Capacity, 2017-2028
8.2 Central Nervous System (CNS) Stimulant Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Central Nervous System (CNS) Stimulant Drugs Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 CENTRAL NERVOUS SYSTEM (CNS) STIMULANT DRUGS SUPPLY CHAIN ANALYSIS
10.1 Central Nervous System (CNS) Stimulant Drugs Industry Value Chain
10.2 Central Nervous System (CNS) Stimulant Drugs Upstream Market
10.3 Central Nervous System (CNS) Stimulant Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Central Nervous System (CNS) Stimulant Drugs Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Central Nervous System (CNS) Stimulant Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Central Nervous System (CNS) Stimulant Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL CENTRAL NERVOUS SYSTEM (CNS) STIMULANT DRUGS OVERALL MARKET SIZE
2.1 Global Central Nervous System (CNS) Stimulant Drugs Market Size: 2021 VS 2028
2.2 Global Central Nervous System (CNS) Stimulant Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Central Nervous System (CNS) Stimulant Drugs Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Central Nervous System (CNS) Stimulant Drugs Players in Global Market
3.2 Top Global Central Nervous System (CNS) Stimulant Drugs Companies Ranked by Revenue
3.3 Global Central Nervous System (CNS) Stimulant Drugs Revenue by Companies
3.4 Global Central Nervous System (CNS) Stimulant Drugs Sales by Companies
3.5 Global Central Nervous System (CNS) Stimulant Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Central Nervous System (CNS) Stimulant Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Central Nervous System (CNS) Stimulant Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Central Nervous System (CNS) Stimulant Drugs Players in Global Market
3.8.1 List of Global Tier 1 Central Nervous System (CNS) Stimulant Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Central Nervous System (CNS) Stimulant Drugs Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Central Nervous System (CNS) Stimulant Drugs Market Size Markets, 2021 & 2028
4.1.2 Amphetamine
4.1.3 Cocaine
4.1.4 Caffeine
4.1.5 Others
4.2 By Type - Global Central Nervous System (CNS) Stimulant Drugs Revenue & Forecasts
4.2.1 By Type - Global Central Nervous System (CNS) Stimulant Drugs Revenue, 2017-2022
4.2.2 By Type - Global Central Nervous System (CNS) Stimulant Drugs Revenue, 2023-2028
4.2.3 By Type - Global Central Nervous System (CNS) Stimulant Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Central Nervous System (CNS) Stimulant Drugs Sales & Forecasts
4.3.1 By Type - Global Central Nervous System (CNS) Stimulant Drugs Sales, 2017-2022
4.3.2 By Type - Global Central Nervous System (CNS) Stimulant Drugs Sales, 2023-2028
4.3.3 By Type - Global Central Nervous System (CNS) Stimulant Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Central Nervous System (CNS) Stimulant Drugs Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Central Nervous System (CNS) Stimulant Drugs Market Size, 2021 & 2028
5.1.2 Attention Deficit Hyperactivity Disorder (ADHD)
5.1.3 Narcolepsy
5.1.4 Others
5.2 By Application - Global Central Nervous System (CNS) Stimulant Drugs Revenue & Forecasts
5.2.1 By Application - Global Central Nervous System (CNS) Stimulant Drugs Revenue, 2017-2022
5.2.2 By Application - Global Central Nervous System (CNS) Stimulant Drugs Revenue, 2023-2028
5.2.3 By Application - Global Central Nervous System (CNS) Stimulant Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Central Nervous System (CNS) Stimulant Drugs Sales & Forecasts
5.3.1 By Application - Global Central Nervous System (CNS) Stimulant Drugs Sales, 2017-2022
5.3.2 By Application - Global Central Nervous System (CNS) Stimulant Drugs Sales, 2023-2028
5.3.3 By Application - Global Central Nervous System (CNS) Stimulant Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Central Nervous System (CNS) Stimulant Drugs Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Central Nervous System (CNS) Stimulant Drugs Market Size, 2021 & 2028
6.2 By Region - Global Central Nervous System (CNS) Stimulant Drugs Revenue & Forecasts
6.2.1 By Region - Global Central Nervous System (CNS) Stimulant Drugs Revenue, 2017-2022
6.2.2 By Region - Global Central Nervous System (CNS) Stimulant Drugs Revenue, 2023-2028
6.2.3 By Region - Global Central Nervous System (CNS) Stimulant Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Central Nervous System (CNS) Stimulant Drugs Sales & Forecasts
6.3.1 By Region - Global Central Nervous System (CNS) Stimulant Drugs Sales, 2017-2022
6.3.2 By Region - Global Central Nervous System (CNS) Stimulant Drugs Sales, 2023-2028
6.3.3 By Region - Global Central Nervous System (CNS) Stimulant Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Central Nervous System (CNS) Stimulant Drugs Revenue, 2017-2028
6.4.2 By Country - North America Central Nervous System (CNS) Stimulant Drugs Sales, 2017-2028
6.4.3 US Central Nervous System (CNS) Stimulant Drugs Market Size, 2017-2028
6.4.4 Canada Central Nervous System (CNS) Stimulant Drugs Market Size, 2017-2028
6.4.5 Mexico Central Nervous System (CNS) Stimulant Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Central Nervous System (CNS) Stimulant Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Central Nervous System (CNS) Stimulant Drugs Sales, 2017-2028
6.5.3 Germany Central Nervous System (CNS) Stimulant Drugs Market Size, 2017-2028
6.5.4 France Central Nervous System (CNS) Stimulant Drugs Market Size, 2017-2028
6.5.5 U.K. Central Nervous System (CNS) Stimulant Drugs Market Size, 2017-2028
6.5.6 Italy Central Nervous System (CNS) Stimulant Drugs Market Size, 2017-2028
6.5.7 Russia Central Nervous System (CNS) Stimulant Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Central Nervous System (CNS) Stimulant Drugs Market Size, 2017-2028
6.5.9 Benelux Central Nervous System (CNS) Stimulant Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Central Nervous System (CNS) Stimulant Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Central Nervous System (CNS) Stimulant Drugs Sales, 2017-2028
6.6.3 China Central Nervous System (CNS) Stimulant Drugs Market Size, 2017-2028
6.6.4 Japan Central Nervous System (CNS) Stimulant Drugs Market Size, 2017-2028
6.6.5 South Korea Central Nervous System (CNS) Stimulant Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Central Nervous System (CNS) Stimulant Drugs Market Size, 2017-2028
6.6.7 India Central Nervous System (CNS) Stimulant Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Central Nervous System (CNS) Stimulant Drugs Revenue, 2017-2028
6.7.2 By Country - South America Central Nervous System (CNS) Stimulant Drugs Sales, 2017-2028
6.7.3 Brazil Central Nervous System (CNS) Stimulant Drugs Market Size, 2017-2028
6.7.4 Argentina Central Nervous System (CNS) Stimulant Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Sales, 2017-2028
6.8.3 Turkey Central Nervous System (CNS) Stimulant Drugs Market Size, 2017-2028
6.8.4 Israel Central Nervous System (CNS) Stimulant Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Central Nervous System (CNS) Stimulant Drugs Market Size, 2017-2028
6.8.6 UAE Central Nervous System (CNS) Stimulant Drugs Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Astellas Pharma
7.1.1 Astellas Pharma Corporate Summary
7.1.2 Astellas Pharma Business Overview
7.1.3 Astellas Pharma Central Nervous System (CNS) Stimulant Drugs Major Product Offerings
7.1.4 Astellas Pharma Central Nervous System (CNS) Stimulant Drugs Sales and Revenue in Global (2017-2022)
7.1.5 Astellas Pharma Key News
7.2 Biogen
7.2.1 Biogen Corporate Summary
7.2.2 Biogen Business Overview
7.2.3 Biogen Central Nervous System (CNS) Stimulant Drugs Major Product Offerings
7.2.4 Biogen Central Nervous System (CNS) Stimulant Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Biogen Key News
7.3 Celltech
7.3.1 Celltech Corporate Summary
7.3.2 Celltech Business Overview
7.3.3 Celltech Central Nervous System (CNS) Stimulant Drugs Major Product Offerings
7.3.4 Celltech Central Nervous System (CNS) Stimulant Drugs Sales and Revenue in Global (2017-2022)
7.3.5 Celltech Key News
7.4 Eli Lilly and Company
7.4.1 Eli Lilly and Company Corporate Summary
7.4.2 Eli Lilly and Company Business Overview
7.4.3 Eli Lilly and Company Central Nervous System (CNS) Stimulant Drugs Major Product Offerings
7.4.4 Eli Lilly and Company Central Nervous System (CNS) Stimulant Drugs Sales and Revenue in Global (2017-2022)
7.4.5 Eli Lilly and Company Key News
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Corporate Summary
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Central Nervous System (CNS) Stimulant Drugs Major Product Offerings
7.5.4 GlaxoSmithKline Central Nervous System (CNS) Stimulant Drugs Sales and Revenue in Global (2017-2022)
7.5.5 GlaxoSmithKline Key News
7.6 Johnson and Johnson
7.6.1 Johnson and Johnson Corporate Summary
7.6.2 Johnson and Johnson Business Overview
7.6.3 Johnson and Johnson Central Nervous System (CNS) Stimulant Drugs Major Product Offerings
7.6.4 Johnson and Johnson Central Nervous System (CNS) Stimulant Drugs Sales and Revenue in Global (2017-2022)
7.6.5 Johnson and Johnson Key News
7.7 Merck
7.7.1 Merck Corporate Summary
7.7.2 Merck Business Overview
7.7.3 Merck Central Nervous System (CNS) Stimulant Drugs Major Product Offerings
7.7.4 Merck Central Nervous System (CNS) Stimulant Drugs Sales and Revenue in Global (2017-2022)
7.7.5 Merck Key News
7.8 Novartis
7.8.1 Novartis Corporate Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Central Nervous System (CNS) Stimulant Drugs Major Product Offerings
7.8.4 Novartis Central Nervous System (CNS) Stimulant Drugs Sales and Revenue in Global (2017-2022)
7.8.5 Novartis Key News
7.9 Perdue Pharma
7.9.1 Perdue Pharma Corporate Summary
7.9.2 Perdue Pharma Business Overview
7.9.3 Perdue Pharma Central Nervous System (CNS) Stimulant Drugs Major Product Offerings
7.9.4 Perdue Pharma Central Nervous System (CNS) Stimulant Drugs Sales and Revenue in Global (2017-2022)
7.9.5 Perdue Pharma Key News
7.10 Pfizer
7.10.1 Pfizer Corporate Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Central Nervous System (CNS) Stimulant Drugs Major Product Offerings
7.10.4 Pfizer Central Nervous System (CNS) Stimulant Drugs Sales and Revenue in Global (2017-2022)
7.10.5 Pfizer Key News
7.11 Roche
7.11.1 Roche Corporate Summary
7.11.2 Roche Central Nervous System (CNS) Stimulant Drugs Business Overview
7.11.3 Roche Central Nervous System (CNS) Stimulant Drugs Major Product Offerings
7.11.4 Roche Central Nervous System (CNS) Stimulant Drugs Sales and Revenue in Global (2017-2022)
7.11.5 Roche Key News
7.12 Sanofi
7.12.1 Sanofi Corporate Summary
7.12.2 Sanofi Central Nervous System (CNS) Stimulant Drugs Business Overview
7.12.3 Sanofi Central Nervous System (CNS) Stimulant Drugs Major Product Offerings
7.12.4 Sanofi Central Nervous System (CNS) Stimulant Drugs Sales and Revenue in Global (2017-2022)
7.12.5 Sanofi Key News
7.13 Shire
7.13.1 Shire Corporate Summary
7.13.2 Shire Central Nervous System (CNS) Stimulant Drugs Business Overview
7.13.3 Shire Central Nervous System (CNS) Stimulant Drugs Major Product Offerings
7.13.4 Shire Central Nervous System (CNS) Stimulant Drugs Sales and Revenue in Global (2017-2022)
7.13.5 Shire Key News
7.14 Takeda Pharmaceuticals
7.14.1 Takeda Pharmaceuticals Corporate Summary
7.14.2 Takeda Pharmaceuticals Business Overview
7.14.3 Takeda Pharmaceuticals Central Nervous System (CNS) Stimulant Drugs Major Product Offerings
7.14.4 Takeda Pharmaceuticals Central Nervous System (CNS) Stimulant Drugs Sales and Revenue in Global (2017-2022)
7.14.5 Takeda Pharmaceuticals Key News
7.15 Thermo Fisher Scientific
7.15.1 Thermo Fisher Scientific Corporate Summary
7.15.2 Thermo Fisher Scientific Business Overview
7.15.3 Thermo Fisher Scientific Central Nervous System (CNS) Stimulant Drugs Major Product Offerings
7.15.4 Thermo Fisher Scientific Central Nervous System (CNS) Stimulant Drugs Sales and Revenue in Global (2017-2022)
7.15.5 Thermo Fisher Scientific Key News
8 GLOBAL CENTRAL NERVOUS SYSTEM (CNS) STIMULANT DRUGS PRODUCTION CAPACITY, ANALYSIS
8.1 Global Central Nervous System (CNS) Stimulant Drugs Production Capacity, 2017-2028
8.2 Central Nervous System (CNS) Stimulant Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Central Nervous System (CNS) Stimulant Drugs Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 CENTRAL NERVOUS SYSTEM (CNS) STIMULANT DRUGS SUPPLY CHAIN ANALYSIS
10.1 Central Nervous System (CNS) Stimulant Drugs Industry Value Chain
10.2 Central Nervous System (CNS) Stimulant Drugs Upstream Market
10.3 Central Nervous System (CNS) Stimulant Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Central Nervous System (CNS) Stimulant Drugs Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Central Nervous System (CNS) Stimulant Drugs in Global Market
Table 2. Top Central Nervous System (CNS) Stimulant Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Central Nervous System (CNS) Stimulant Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Central Nervous System (CNS) Stimulant Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Central Nervous System (CNS) Stimulant Drugs Sales by Companies, (MT), 2017-2022
Table 6. Global Central Nervous System (CNS) Stimulant Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Central Nervous System (CNS) Stimulant Drugs Price (2017-2022) & (USD/MT)
Table 8. Global Manufacturers Central Nervous System (CNS) Stimulant Drugs Product Type
Table 9. List of Global Tier 1 Central Nervous System (CNS) Stimulant Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Central Nervous System (CNS) Stimulant Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Central Nervous System (CNS) Stimulant Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Central Nervous System (CNS) Stimulant Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Central Nervous System (CNS) Stimulant Drugs Sales (MT), 2017-2022
Table 15. By Type - Global Central Nervous System (CNS) Stimulant Drugs Sales (MT), 2023-2028
Table 16. By Application – Global Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Central Nervous System (CNS) Stimulant Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Central Nervous System (CNS) Stimulant Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Central Nervous System (CNS) Stimulant Drugs Sales (MT), 2017-2022
Table 20. By Application - Global Central Nervous System (CNS) Stimulant Drugs Sales (MT), 2023-2028
Table 21. By Region – Global Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Central Nervous System (CNS) Stimulant Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Central Nervous System (CNS) Stimulant Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Central Nervous System (CNS) Stimulant Drugs Sales (MT), 2017-2022
Table 25. By Region - Global Central Nervous System (CNS) Stimulant Drugs Sales (MT), 2023-2028
Table 26. By Country - North America Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Central Nervous System (CNS) Stimulant Drugs Sales, (MT), 2017-2022
Table 29. By Country - North America Central Nervous System (CNS) Stimulant Drugs Sales, (MT), 2023-2028
Table 30. By Country - Europe Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Central Nervous System (CNS) Stimulant Drugs Sales, (MT), 2017-2022
Table 33. By Country - Europe Central Nervous System (CNS) Stimulant Drugs Sales, (MT), 2023-2028
Table 34. By Region - Asia Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Central Nervous System (CNS) Stimulant Drugs Sales, (MT), 2017-2022
Table 37. By Region - Asia Central Nervous System (CNS) Stimulant Drugs Sales, (MT), 2023-2028
Table 38. By Country - South America Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Central Nervous System (CNS) Stimulant Drugs Sales, (MT), 2017-2022
Table 41. By Country - South America Central Nervous System (CNS) Stimulant Drugs Sales, (MT), 2023-2028
Table 42. By Country - Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Sales, (MT), 2017-2022
Table 45. By Country - Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Sales, (MT), 2023-2028
Table 46. Astellas Pharma Corporate Summary
Table 47. Astellas Pharma Central Nervous System (CNS) Stimulant Drugs Product Offerings
Table 48. Astellas Pharma Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 49. Biogen Corporate Summary
Table 50. Biogen Central Nervous System (CNS) Stimulant Drugs Product Offerings
Table 51. Biogen Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 52. Celltech Corporate Summary
Table 53. Celltech Central Nervous System (CNS) Stimulant Drugs Product Offerings
Table 54. Celltech Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 55. Eli Lilly and Company Corporate Summary
Table 56. Eli Lilly and Company Central Nervous System (CNS) Stimulant Drugs Product Offerings
Table 57. Eli Lilly and Company Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 58. GlaxoSmithKline Corporate Summary
Table 59. GlaxoSmithKline Central Nervous System (CNS) Stimulant Drugs Product Offerings
Table 60. GlaxoSmithKline Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 61. Johnson and Johnson Corporate Summary
Table 62. Johnson and Johnson Central Nervous System (CNS) Stimulant Drugs Product Offerings
Table 63. Johnson and Johnson Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 64. Merck Corporate Summary
Table 65. Merck Central Nervous System (CNS) Stimulant Drugs Product Offerings
Table 66. Merck Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 67. Novartis Corporate Summary
Table 68. Novartis Central Nervous System (CNS) Stimulant Drugs Product Offerings
Table 69. Novartis Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 70. Perdue Pharma Corporate Summary
Table 71. Perdue Pharma Central Nervous System (CNS) Stimulant Drugs Product Offerings
Table 72. Perdue Pharma Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 73. Pfizer Corporate Summary
Table 74. Pfizer Central Nervous System (CNS) Stimulant Drugs Product Offerings
Table 75. Pfizer Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 76. Roche Corporate Summary
Table 77. Roche Central Nervous System (CNS) Stimulant Drugs Product Offerings
Table 78. Roche Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 79. Sanofi Corporate Summary
Table 80. Sanofi Central Nervous System (CNS) Stimulant Drugs Product Offerings
Table 81. Sanofi Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 82. Shire Corporate Summary
Table 83. Shire Central Nervous System (CNS) Stimulant Drugs Product Offerings
Table 84. Shire Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 85. Takeda Pharmaceuticals Corporate Summary
Table 86. Takeda Pharmaceuticals Central Nervous System (CNS) Stimulant Drugs Product Offerings
Table 87. Takeda Pharmaceuticals Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 88. Thermo Fisher Scientific Corporate Summary
Table 89. Thermo Fisher Scientific Central Nervous System (CNS) Stimulant Drugs Product Offerings
Table 90. Thermo Fisher Scientific Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 91. Central Nervous System (CNS) Stimulant Drugs Production Capacity (MT) of Key Manufacturers in Global Market, 2020-2022 (MT)
Table 92. Global Central Nervous System (CNS) Stimulant Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 93. Global Central Nervous System (CNS) Stimulant Drugs Production by Region, 2017-2022 (MT)
Table 94. Global Central Nervous System (CNS) Stimulant Drugs Production by Region, 2023-2028 (MT)
Table 95. Central Nervous System (CNS) Stimulant Drugs Market Opportunities & Trends in Global Market
Table 96. Central Nervous System (CNS) Stimulant Drugs Market Drivers in Global Market
Table 97. Central Nervous System (CNS) Stimulant Drugs Market Restraints in Global Market
Table 98. Central Nervous System (CNS) Stimulant Drugs Raw Materials
Table 99. Central Nervous System (CNS) Stimulant Drugs Raw Materials Suppliers in Global Market
Table 100. Typical Central Nervous System (CNS) Stimulant Drugs Downstream
Table 101. Central Nervous System (CNS) Stimulant Drugs Downstream Clients in Global Market
Table 102. Central Nervous System (CNS) Stimulant Drugs Distributors and Sales Agents in Global Market
Table 1. Key Players of Central Nervous System (CNS) Stimulant Drugs in Global Market
Table 2. Top Central Nervous System (CNS) Stimulant Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Central Nervous System (CNS) Stimulant Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Central Nervous System (CNS) Stimulant Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Central Nervous System (CNS) Stimulant Drugs Sales by Companies, (MT), 2017-2022
Table 6. Global Central Nervous System (CNS) Stimulant Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Central Nervous System (CNS) Stimulant Drugs Price (2017-2022) & (USD/MT)
Table 8. Global Manufacturers Central Nervous System (CNS) Stimulant Drugs Product Type
Table 9. List of Global Tier 1 Central Nervous System (CNS) Stimulant Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Central Nervous System (CNS) Stimulant Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Central Nervous System (CNS) Stimulant Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Central Nervous System (CNS) Stimulant Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Central Nervous System (CNS) Stimulant Drugs Sales (MT), 2017-2022
Table 15. By Type - Global Central Nervous System (CNS) Stimulant Drugs Sales (MT), 2023-2028
Table 16. By Application – Global Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Central Nervous System (CNS) Stimulant Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Central Nervous System (CNS) Stimulant Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Central Nervous System (CNS) Stimulant Drugs Sales (MT), 2017-2022
Table 20. By Application - Global Central Nervous System (CNS) Stimulant Drugs Sales (MT), 2023-2028
Table 21. By Region – Global Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Central Nervous System (CNS) Stimulant Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Central Nervous System (CNS) Stimulant Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Central Nervous System (CNS) Stimulant Drugs Sales (MT), 2017-2022
Table 25. By Region - Global Central Nervous System (CNS) Stimulant Drugs Sales (MT), 2023-2028
Table 26. By Country - North America Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Central Nervous System (CNS) Stimulant Drugs Sales, (MT), 2017-2022
Table 29. By Country - North America Central Nervous System (CNS) Stimulant Drugs Sales, (MT), 2023-2028
Table 30. By Country - Europe Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Central Nervous System (CNS) Stimulant Drugs Sales, (MT), 2017-2022
Table 33. By Country - Europe Central Nervous System (CNS) Stimulant Drugs Sales, (MT), 2023-2028
Table 34. By Region - Asia Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Central Nervous System (CNS) Stimulant Drugs Sales, (MT), 2017-2022
Table 37. By Region - Asia Central Nervous System (CNS) Stimulant Drugs Sales, (MT), 2023-2028
Table 38. By Country - South America Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Central Nervous System (CNS) Stimulant Drugs Sales, (MT), 2017-2022
Table 41. By Country - South America Central Nervous System (CNS) Stimulant Drugs Sales, (MT), 2023-2028
Table 42. By Country - Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Sales, (MT), 2017-2022
Table 45. By Country - Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Sales, (MT), 2023-2028
Table 46. Astellas Pharma Corporate Summary
Table 47. Astellas Pharma Central Nervous System (CNS) Stimulant Drugs Product Offerings
Table 48. Astellas Pharma Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 49. Biogen Corporate Summary
Table 50. Biogen Central Nervous System (CNS) Stimulant Drugs Product Offerings
Table 51. Biogen Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 52. Celltech Corporate Summary
Table 53. Celltech Central Nervous System (CNS) Stimulant Drugs Product Offerings
Table 54. Celltech Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 55. Eli Lilly and Company Corporate Summary
Table 56. Eli Lilly and Company Central Nervous System (CNS) Stimulant Drugs Product Offerings
Table 57. Eli Lilly and Company Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 58. GlaxoSmithKline Corporate Summary
Table 59. GlaxoSmithKline Central Nervous System (CNS) Stimulant Drugs Product Offerings
Table 60. GlaxoSmithKline Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 61. Johnson and Johnson Corporate Summary
Table 62. Johnson and Johnson Central Nervous System (CNS) Stimulant Drugs Product Offerings
Table 63. Johnson and Johnson Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 64. Merck Corporate Summary
Table 65. Merck Central Nervous System (CNS) Stimulant Drugs Product Offerings
Table 66. Merck Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 67. Novartis Corporate Summary
Table 68. Novartis Central Nervous System (CNS) Stimulant Drugs Product Offerings
Table 69. Novartis Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 70. Perdue Pharma Corporate Summary
Table 71. Perdue Pharma Central Nervous System (CNS) Stimulant Drugs Product Offerings
Table 72. Perdue Pharma Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 73. Pfizer Corporate Summary
Table 74. Pfizer Central Nervous System (CNS) Stimulant Drugs Product Offerings
Table 75. Pfizer Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 76. Roche Corporate Summary
Table 77. Roche Central Nervous System (CNS) Stimulant Drugs Product Offerings
Table 78. Roche Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 79. Sanofi Corporate Summary
Table 80. Sanofi Central Nervous System (CNS) Stimulant Drugs Product Offerings
Table 81. Sanofi Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 82. Shire Corporate Summary
Table 83. Shire Central Nervous System (CNS) Stimulant Drugs Product Offerings
Table 84. Shire Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 85. Takeda Pharmaceuticals Corporate Summary
Table 86. Takeda Pharmaceuticals Central Nervous System (CNS) Stimulant Drugs Product Offerings
Table 87. Takeda Pharmaceuticals Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 88. Thermo Fisher Scientific Corporate Summary
Table 89. Thermo Fisher Scientific Central Nervous System (CNS) Stimulant Drugs Product Offerings
Table 90. Thermo Fisher Scientific Central Nervous System (CNS) Stimulant Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 91. Central Nervous System (CNS) Stimulant Drugs Production Capacity (MT) of Key Manufacturers in Global Market, 2020-2022 (MT)
Table 92. Global Central Nervous System (CNS) Stimulant Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 93. Global Central Nervous System (CNS) Stimulant Drugs Production by Region, 2017-2022 (MT)
Table 94. Global Central Nervous System (CNS) Stimulant Drugs Production by Region, 2023-2028 (MT)
Table 95. Central Nervous System (CNS) Stimulant Drugs Market Opportunities & Trends in Global Market
Table 96. Central Nervous System (CNS) Stimulant Drugs Market Drivers in Global Market
Table 97. Central Nervous System (CNS) Stimulant Drugs Market Restraints in Global Market
Table 98. Central Nervous System (CNS) Stimulant Drugs Raw Materials
Table 99. Central Nervous System (CNS) Stimulant Drugs Raw Materials Suppliers in Global Market
Table 100. Typical Central Nervous System (CNS) Stimulant Drugs Downstream
Table 101. Central Nervous System (CNS) Stimulant Drugs Downstream Clients in Global Market
Table 102. Central Nervous System (CNS) Stimulant Drugs Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Central Nervous System (CNS) Stimulant Drugs Segment by Type
Figure 2. Central Nervous System (CNS) Stimulant Drugs Segment by Application
Figure 3. Global Central Nervous System (CNS) Stimulant Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Central Nervous System (CNS) Stimulant Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Central Nervous System (CNS) Stimulant Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Central Nervous System (CNS) Stimulant Drugs Sales in Global Market: 2017-2028 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Central Nervous System (CNS) Stimulant Drugs Revenue in 2021
Figure 9. By Type - Global Central Nervous System (CNS) Stimulant Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Central Nervous System (CNS) Stimulant Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Central Nervous System (CNS) Stimulant Drugs Price (USD/MT), 2017-2028
Figure 12. By Application - Global Central Nervous System (CNS) Stimulant Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Central Nervous System (CNS) Stimulant Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Central Nervous System (CNS) Stimulant Drugs Price (USD/MT), 2017-2028
Figure 15. By Region - Global Central Nervous System (CNS) Stimulant Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Central Nervous System (CNS) Stimulant Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Central Nervous System (CNS) Stimulant Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Central Nervous System (CNS) Stimulant Drugs Sales Market Share, 2017-2028
Figure 19. US Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Central Nervous System (CNS) Stimulant Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Central Nervous System (CNS) Stimulant Drugs Sales Market Share, 2017-2028
Figure 24. Germany Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Central Nervous System (CNS) Stimulant Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Central Nervous System (CNS) Stimulant Drugs Sales Market Share, 2017-2028
Figure 33. China Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Central Nervous System (CNS) Stimulant Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Central Nervous System (CNS) Stimulant Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Central Nervous System (CNS) Stimulant Drugs Production Capacity (MT), 2017-2028
Figure 49. The Percentage of Production Central Nervous System (CNS) Stimulant Drugs by Region, 2021 VS 2028
Figure 50. Central Nervous System (CNS) Stimulant Drugs Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Central Nervous System (CNS) Stimulant Drugs Segment by Type
Figure 2. Central Nervous System (CNS) Stimulant Drugs Segment by Application
Figure 3. Global Central Nervous System (CNS) Stimulant Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Central Nervous System (CNS) Stimulant Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Central Nervous System (CNS) Stimulant Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Central Nervous System (CNS) Stimulant Drugs Sales in Global Market: 2017-2028 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Central Nervous System (CNS) Stimulant Drugs Revenue in 2021
Figure 9. By Type - Global Central Nervous System (CNS) Stimulant Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Central Nervous System (CNS) Stimulant Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Central Nervous System (CNS) Stimulant Drugs Price (USD/MT), 2017-2028
Figure 12. By Application - Global Central Nervous System (CNS) Stimulant Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Central Nervous System (CNS) Stimulant Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Central Nervous System (CNS) Stimulant Drugs Price (USD/MT), 2017-2028
Figure 15. By Region - Global Central Nervous System (CNS) Stimulant Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Central Nervous System (CNS) Stimulant Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Central Nervous System (CNS) Stimulant Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Central Nervous System (CNS) Stimulant Drugs Sales Market Share, 2017-2028
Figure 19. US Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Central Nervous System (CNS) Stimulant Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Central Nervous System (CNS) Stimulant Drugs Sales Market Share, 2017-2028
Figure 24. Germany Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Central Nervous System (CNS) Stimulant Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Central Nervous System (CNS) Stimulant Drugs Sales Market Share, 2017-2028
Figure 33. China Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Central Nervous System (CNS) Stimulant Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Central Nervous System (CNS) Stimulant Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Central Nervous System (CNS) Stimulant Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Central Nervous System (CNS) Stimulant Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Central Nervous System (CNS) Stimulant Drugs Production Capacity (MT), 2017-2028
Figure 49. The Percentage of Production Central Nervous System (CNS) Stimulant Drugs by Region, 2021 VS 2028
Figure 50. Central Nervous System (CNS) Stimulant Drugs Industry Value Chain
Figure 51. Marketing Channels
